Puri; Raj
Patent Applications and Registrations
Patent applications and USPTO patent grants for Puri; Raj.The latest application filed is for "use of cysteamine and derivatives thereof to suppress tumor metastases".
- Puri; Raj - Bethesda MD
- Puri; Raj - Potomac MD US
| Patent | Date |
|---|---|
| Use of cysteamine and derivatives thereof to suppress tumor metastases Grant 11,052,057 - Rubin , et al. July 6, 2 | 2021-07-06 |
| Use Of Cysteamine And Derivatives Thereof To Suppress Tumor Metastases App 20200147010 - RUBIN; Benjamin ; et al. | 2020-05-14 |
| Use Of Cysteamine And Derivatives Thereof To Suppress Tumor Metastases App 20190142769 - RUBIN; Benjamin ; et al. | 2019-05-16 |
| Use Of Cysteamine And Derivatives Thereof To Suppress Tumor Metastases App 20180042870 - RUBIN; Benjamin ; et al. | 2018-02-15 |
| Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells Grant 9,072,716 - Strober , et al. July 7, 2 | 2015-07-07 |
| Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells App 20090092543 - Strober; Warren ; et al. | 2009-04-09 |
| Selective treatment of IL-13 expressing tumors App 20050002918 - Strauss, Lewis ; et al. | 2005-01-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 